JPRN-UMIN000003825已完成未知
asal provocation test in pediatric patients with perennial allergic rhinitis - Nasal provocation test in pediatric patients with perennial allergic rhinitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10years-old 至 14years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with acute rhinits, simple rhinitis, atgrophic rhinitis, and sinusitis. 2. Patients with nasal obstruction attributable to nasal polyps or nasal deformity. 3. Patients who have undergone immunotherapy with housedust/mite. 4. Patients who have undergone nasal operation such as turbinectomy, choncotomy, and laser surgery. 5. Patients who show complete nasal obstruction after induced a control disc. 6. Patients with uncontrolled asthma. 7. Patients with severe drug allergy. 8. Patients who used anti-allergic or anti-histamine drugs within one week or steroid within one month prior to the start of this study. 9. Patients with allergic diseases except allergic rhinitis such as atopic dermatitis or food allergy which might not show exacerbation after nasal provocation test.
研究者
相似试验
已完成
不适用
Paediatric onset study to assess the efficacy of insulin pump therapy using the MiniMed Paradigm® REAL-Time system during the first year of diabetes in children and adolescents with type 1 diabetesType 1 diabetes mellitusISRCTN05450731Hannover Childrens Hospital (Hannoversche Kinderheilanstalt) (Germany)160
已完成
不适用
Estimating activity of the drug Peglyated Asparginase in children with Blood cancer (Acute Lymphoblastic Leukemia)CTRI/2021/08/036033Manipal Academy of Higher Education10
已完成
不适用
Development and Validation of Pediatric Simple Malnutrition Risk Score for Hospitalized Pediatric Patients in Thailand: PSMaRTSick pediatric patients who admit in pediatric wards.malnutritionNutritional deteriorationrisk scoreTCTR20201001001/A140
进行中（未招募）
不适用
PROSPECTIVE CLINICAL STUDY IN CHILDREN WITH SEVERE HAEMOPHILIA A TO INVESTIGATE CLINICAL EFFICACY, IMMUNOGENICITY, PHARMACOKINETICS, AND SAFETY OF HUMAN-CL RHFVIIISevere Haemophilia AMedDRA version: 12.1Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)EUCTR2010-018644-14-ATOctapharma AG60
进行中（未招募）
不适用
PROSPECTIVE CLINICAL STUDY IN CHILDREN WITH SEVERE HAEMOPHILIA A TO INVESTIGATE CLINICAL EFFICACY, IMMUNOGENICITY, PHARMACOKINETICS, AND SAFETY OF HUMAN-CL RHFVIII - GENA-03Severe Haemophilia AEUCTR2010-018644-14-GBOctapharma AG60